Teladoc Health, Inc. TDOC is taking a significant step forward in virtual care by integrating TytoCare’s FDA-approved Home Smart Clinic into its popular Primary360 and 24/7 Care programs. Starting in 2026, some members will be able to access clinical-grade remote exams using TytoCare’s handy diagnostic device. This move represents one of the most comprehensive enhancements to in-home care options within the telehealth landscape.
TytoCare’s innovative technology enables remote assessment of lungs, heart, throat, ear, skin and temperature, closing like an in-person examination. The standout feature is its recently FDA-cleared AI-powered Lung Sounds Suite, which was recently honored as a TIME 2025 Best Invention. This tool can distinguish between the three most common abnormal lung sounds, marking a significant advancement, especially since respiratory issues account for over 40% of diagnoses on the TytoCare platform.
For TDOC, this integration strengthens its competitive edge at a time when virtual care providers are under pressure to demonstrate their long-term value and sustainability. For employers and health plans, this change could mean quicker interventions, a reduction in unnecessary ER visits and better ongoing care for chronic issues like asthma or hypertension. TytoCare’s extensive health dataset of over 7 million recorded exams boosts both diagnostic confidence and the accuracy of models.
This move also aligns with a broader trend in healthcare — bringing diagnostics closer to the patient. With more people wanting care at home, integrated AI diagnostics might soon be the norm instead of just a unique feature.
However, the execution of this plan will be key. The rollout is set to begin with a select group of customers, which indicates TDOC is cautiously testing adoption, utilization rates and reimbursement alignment. If executed well and reflects TytoCare’s historical performance, then this integration could become a scalable advantage.
TDOC’s Price Performance
Year to date, TDOC shares have declined 23% against the industry’s growth of 4.9%.
Image Source: Zacks Investment Research
TDOC’s Zacks Rank & Key Picks
TDOC currently carries a Zacks Rank #3 (Hold).
Some top-ranked stocks in the Medical space are BrightSpring Health Services, Inc. BTSG, Universal Health Services, Inc. UHS and Veracyte, Inc. VCYT, each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for BrightSpring Health Services’ current-year earnings of $1.12 per share has witnessed three upward revisions in the past 30 days against no movement in the opposite direction. BrightSpring Health Services beat earnings estimates in each of the trailing four quarters, with the average surprise being 45.1%. The consensus estimate for current-year revenues is pegged at $12.7 billion, suggesting 12.8% year-over-year growth.
The Zacks Consensus Estimate for Universal Health’s current-year earnings of $21.67 per share has witnessed six upward revisions in the past 30 days against no movement in the opposite direction. Universal Health beat earnings estimates in each of the trailing four quarters, with the average surprise being 15.2%. The consensus estimate for current-year revenues is pegged at $17.4 billion, suggesting 9.7% year-over-year growth.
The Zacks Consensus Estimate for Veracyte’s current-year earnings of $1.42 per share has witnessed one upward revision in the past 60 days against no movement in the opposite direction. Veracyte beat earnings estimates in each of the trailing four quarters, with an average surprise being 45.1%. The consensus estimate for current-year revenues is pegged at $508.6 million, suggesting 14.1% year-over-year growth.
#1 Semiconductor Stock to Buy (Not NVDA)
The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.
One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.
See This Stock Now for Free >>Universal Health Services, Inc. (UHS) : Free Stock Analysis Report
Teladoc Health, Inc. (TDOC) : Free Stock Analysis Report
Veracyte, Inc. (VCYT) : Free Stock Analysis Report
BrightSpring Health Services, Inc. (BTSG) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
